Leonard Bell, Director at ALEXION PHARMACEUTICALS INC (ALXN), sold 15,872 shares at $143.81 ($2.2M) on 2016-02-04, disclosed to the SEC on 2016-02-08.
Seasonal sale ($2.2M) by Director — this insider has traded ALXN in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $143.81 | 2,227 | $320K | 14.5% |
| 2 | $144.95 | 35 | $5K | 0.2% |
| 3 | $140.83 | 44 | $6K | 0.3% |
| 4 | $141.38 | 592 | $84K | 3.8% |
| 5 | $142.26 | 400 | $57K | 2.6% |
| 6 | $143.39 | 300 |
| $43K |
| 1.9% |
| 7 | $144.32 | 400 | $58K | 2.6% |
| 8 | $145.40 | 400 | $58K | 2.6% |
| 9 | $138.02 | 1,037 | $143K | 6.5% |
| 10 | $138.02 | 10,092 | $1.4M | 62.9% |
| 11 | $140.34 | 345 | $48K | 2.2% |
| Total | $139.58 avg | 15,872 | $2.2M | 100% |
| Filing → |
| ALXN | SELL | 2017-02-08 | $2.2M | — | Filing → |
| ALXN | SELL | 2017-01-13 | $14K | — | Filing → |
| ALXN | SELL | 2017-01-09 | $5.5M | — | Filing → |